Study shows pramipexole relieves RLS
Boehringer Ingelheim's latest clinical study investigating pramipexole on Restless Legs Syndrome (RLS) reveals a marked improvement over dopamine, which is the current preferred treatment for the millions that suffer from this debilitating disease.